Patients are returning in Europe, but China and US lag behind, says Coloplast's CEO

Things are looking better in Europe for Medtech firm Coloplast, as patient numbers are returning to pre-Covid-19 levels. However, challenges remain outside the region, CEO Kristian Villumsen says.
Kristian Villumsen, CEO of Coloplast | Photo: Stine Bidstrup/ERH
Kristian Villumsen, CEO of Coloplast | Photo: Stine Bidstrup/ERH
by marketwire, translated by daniel pedersen

Signs of a patient influx recovery for Coloplast’s segment have appeared – particularly in Europe, where the patient numbers are almost the same as prior to the Covid-10 pandemic, says the medtech company’s CEO, Kristian Villumsen, in an interview with MarketWire.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading